Purpose/Objective: The microscopic uncertainty of the energy imparted (microdosimetric spread) at the cellular/cell nuclei level due to the stochastic nature of ionizing radiation is seldom taken into account in the parameterization of survival fraction data. The magnitude of the microdosimetric spread is expected to be higher for protons than for photons because of the known differences in their track structure but very little data has been published on the matter. The aim of this work is to find the possible impact that variances in the microdosimetric spread for a cell population with diverse volume sizes may have on the radiation response. Particularly we focus on estimating the effect on the α and β parameters of the linear quadratic (LQ) model used to describe experimentally obtained cell survival curves. Materials and Methods: The Monte Carlo transport code LIonTrack was used to simulate event-by-event proton tracks in liquid water for the energies 0.91, 1.4, 1.72, 3.18, 3.59, and 4.97 MeVu -1 , as well as for a 60 Co source. In-house analysis codes were used to calculate the magnitude of the microdosimetric spread σ z , for each radiation source and for a range of spherical volume sizes typical of cell nuclei. Experimentally obtained survival curves intrinsically account for the microdosimetric spread. To determine the α and β values that 'exclude' such variations a convolution of the dose dependent distribution of specific energies f (z,D) (which is a normal distribution characterized with mean D and a standard deviation σ z ) with the LQ equation, exp[-(αD+βD 2 )] was performed, and then fitting α and β to survival curves calculated from published α exp and β exp values experimentally obtained from exposure of V-79 cells. The RBE 10 at 10% survival with 60 Co as the reference radiation for both the resulting α and β values and the α exp and β exp were calculated. Results: The σ z decreases with dose and size of the target volume for all radiation sources but increases with decreasing proton energy. For a typical fraction dose of 2 Gy, σ z for a diameter of 10 µm is equal to 9% and 18% for the highest and lowest proton energy, respectively. The σ z reaches 87% and 175%, respectively, for a diameter equal to 1 µm. In contrast, σ z for 60 Co is 1.7% and 31% for 10 and 1 µm diameter. The ratio of RBE 10 calculated by excluding σ z with respect to the experimentally obtained, decreases with decrease in LET and volume. For 0.91 MeVu -1 protons, the difference ranges from 20% to 2% for spheres with diameters 4 and 12 µm, respectively. That is in contrast to 4.98 MeVu -1 protons for which the difference does not exceed 3% for all volumes. Conclusions: Our data suggests that the microdosimetric spread in the experimental data smears out the higher efficiency of the RBE if the cell culture would consist of equal small volumes (up to 4 µm diameter). The impact of the microdosimetric spread in the clinical scenario when the irradiated volume consists of cells with diverse diameters all mixed together should be analysed.
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